In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 89089-18-9, name is 3-Bromo-6-chloropyridazine, introducing its new discovery. HPLC of Formula: C4H2BrClN2
HETEROCYCLIC COMPOUND
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of central nervous system diseases including neurodegenerative disease, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 89089-18-9, and how the biochemistry of the body works.HPLC of Formula: C4H2BrClN2
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N2840 – PubChem